Cefonicid sodium

CAS No. 61270-78-8

Cefonicid sodium ( Monocid )

Catalog No. M15306 CAS No. 61270-78-8

Cefonicid sodium is a broadspectrum cephalosporin antibiotic which inhibits the formation of the bacterial cell wall.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 34 In Stock
50MG 50 In Stock
100MG 70 In Stock
200MG 104 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cefonicid sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Cefonicid sodium is a broadspectrum cephalosporin antibiotic which inhibits the formation of the bacterial cell wall.
  • Description
    Cefonicid sodium is a broadspectrum cephalosporin antibiotic which inhibits the formation of the bacterial cell wall.
  • Synonyms
    Monocid
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    PBPs
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    61270-78-8
  • Formula Weight
    586.53
  • Molecular Formula
    C18H16N6Na2O8S3
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)O)C(=O)[O-])CSC4=NN=NN4CS(=O)(=O)[O-].[Na+].[Na+]
  • Chemical Name
    disodium;(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfonatomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rake JB, et al. J Antibiot (Tokyo). 1984 May;37(5):572-6.
molnova catalog
related products
  • Ciprofloxacin hydroc...

    Ciprofloxacin hydrochloride hydrate is a fluoroquinolone antibioticis an antibiotic used to treat a number of bacterial infections.

  • Cefaclor monohydrate

    Semisynthetic, broad-spectrum antibiotic derivative of cephalexin.

  • Garenoxacin mesylate...

    A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.